Today

Agents

Chat

Arena

Discover

More

App

J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3 - JNJ News | Rallies

J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3

JNJ•2026-08-17

FDA clearance for Monarch Quest 3

Aug. 17 (Reuters) - Johnson & Johnson announced Monarch™ Quest 3, advancing the latest in robotically-assisted bronchoscopy.

Johnson & Johnson announces Monarch™ Quest 3, advancing the latest in robotically-assisted bronchoscopy

Further company coverage: JNJ.N

Related News

Bouwinvest outlook shows sustainable prime offices outperform as tenant demand turns selective

XLRE•2026-08-17

Skyline Builders Group buys Mill Creek, Irwin gold-silver properties in Nevada

KAZR•2026-08-17

Upland Software partners with Carahsoft to expand public sector distribution of knowledge management tools

UPLD•2026-08-17

Nvidia OpenAI committed to substantial deployments of Nvidia AI infrastructure through 2030

NVDA•2026-08-17

Centene taps Chris Neczypor to succeed retiring CFO Drew Asher

CNC•2026-08-17